Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy.
Crohn
Dynamic CEUS
Endoscopic remission
IBD
Response to therapy
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
16
03
2020
revised:
01
07
2020
accepted:
02
08
2020
pubmed:
10
9
2020
medline:
1
2
2022
entrez:
9
9
2020
Statut:
ppublish
Résumé
To evaluate whether changes in bowel perfusion parameters measured by dynamic-CEUS (D-CEUS) can be used for monitoring response to therapy in active Crohn disease (CD). Fifty-four CD patients were evaluated with d-CEUS before (T0) and after 2 (T1), 6 (T2) and 12 weeks (T3) of anti-TNFα therapy. Variations from baseline were calculated for: peak intensity, PI; area under the curve, AUC; slope of wash in, P 70% of patients achieved combined endoscopic/clinical response (responders). The reduction in PI, AUC, P d-CEUS might become a reliable predictor of combined endoscopic/clinical response and clinical relapse in CD.
Identifiants
pubmed: 32900648
pii: S1590-8658(20)30399-6
doi: 10.1016/j.dld.2020.08.005
pii:
doi:
Substances chimiques
Tumor Necrosis Factor Inhibitors
0
Infliximab
B72HH48FLU
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
729-737Informations de copyright
Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest No potential conflicts of interest. No financial support.